U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07905235) titled 'Targeted Antimicrobial Comparison for Treatment Individualization in Critically Ill Patients With CRAB Infection' on Oct. 15.
Brief Summary: The goal of this prospective, multicenter observational study is to learn which antibiotic treatment strategies are associated with better outcomes in critically ill adults with severe infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB). The study will also evaluate the safety and costs of different treatments and develop prediction models to support personalized treatment decisions.
The main questions it aims to answer are:
Are there differences in 28-day survival betwee...